Evidence map›Paper›PMID 35665324›Full record

ArticleFrontiers in medicine2022

Tracking SARS-CoV-2 Variants Using a Rapid Typification Strategy: A Key Tool for Early Detection and Spread Investigation of Omicron in Argentina.

Gonzalo M Castro, Paola Sicilia, María Laura Bolzon, Laura Lopez, María Gabriela Barbás, María Belén Pisano, Viviana E Ré

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. [Performance of prognostic scores during the first and second waves of COVID-19 pneumonia]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Gonzalo M CastroLaboratorio Central de la Provincia de Córdoba, Ministerio de Salud, Gobierno de la Provincia de Córdoba, Córdoba, Argentina.
Paola SiciliaLaboratorio Central de la Provincia de Córdoba, Ministerio de Salud, Gobierno de la Provincia de Córdoba, Córdoba, Argentina.
María Laura BolzonLaboratorio Central de la Provincia de Córdoba, Ministerio de Salud, Gobierno de la Provincia de Córdoba, Córdoba, Argentina.
Laura LopezÁrea de Epidemiología, Ministerio de Salud, Gobierno de la Provincia de Córdoba, Córdoba, Argentina.
María Gabriela BarbásSecretaría de Prevención y Promoción de la Salud, Ministerio de Salud, Gobierno de la Provincia de Córdoba, Córdoba, Argentina.
María Belén PisanoInstituto de Virología "Dr. J. M. Vanella", CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Viviana E RéInstituto de Virología "Dr. J. M. Vanella", CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Ministerio de Salud - Provincia de Buenos Aires · ARMinisterio de Salud · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Nacional de Córdoba · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 variants of concern (VOC) and interest (VOI) present mutations in reference to the original virus, being more transmissible. We implemented a rapid strategy for the screening of SARS-CoV-2 VOC/VOIs using real time RT-PCR and performed monitoring and surveillance of the variants in our region. Consecutive real-time RT-PCRs for detection of the relevant mutations/deletions present in the Spike protein in VOC/VOIs (TaqMan™ SARS-CoV-2 Mutation Panel, Applied Biosystems) were implemented. A total of 6,640 SARS-CoV-2 RNA samples (Cts < 30) from infected individuals in Central Argentina during 2021 were analyzed using different algorithms that were gradually adapted to the changing scenarios of local variant circulation. The strategy developed allowed the early detection and the identification of VOC/VOIs that circulated through the year, with a 100% of concordance with the WGS. The analyses of the samples showed introductions of VOCs Alpha and Gamma in February and March 2021, respectively. Gamma showed an exponential increase, with a peak of detection in July (72%), being responsible of the second wave of COVID19 in Argentina. Since VOC Delta entered into the region, it increased gradually, together with VOI Lambda, replacing VOC Gamma, until being the main variant (84.9%) on November. By December, these variants were replaced by the emergent VOC Omicron in a term of 2 weeks, producing the third wave. We report a useful tool for VOC/VOI detection, capable to quickly and cost-effectively monitor currently recognized variants in resource-limited settings, which allowed to track the recent expansion of Omicron in our region, and contributed to the implementation of public health measures to control the disease spread.

Indexed as

diagnosisOmicronrapid screeningreal time RT-PCRSARS-CoV-2variants of concern (VOCs)

Identifiers

PMID35665324
PMCPMC9157384
OpenAlexW4280652622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.